All lobbying filings

AVENUE SOLUTIONS

AVENUE SOLUTIONS filed a Q1 report for EDWARDS LIFESCIENCES LLC on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for EDWARDS LIFESCIENCES LLC · Patient-focused innovations for structural heart disease and critical care monitoring

All filings by AVENUE SOLUTIONS · Everything EDWARDS LIFESCIENCES LLC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

AMY TEJRAL New on this filing

Previously held: Legislative Director, Sen. Ben Nelson

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process

Bills named in this filing 2

H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.